Sources | Names Used |
---|---|
GDSC1000, FIMM | Cytarabine |
CTRPv2 | cytarabine hydrochloride |
PharmacoGx | Cytarabine |
Database | Identifier |
---|---|
Smiles: | C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O.Cl |
Inchikey: | KCURWTAZOZXKSJ-UHFFFAOYSA-N |
Pubchem: | 5351180 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DAPP1 | GDSC1000 | pan-cancer | AAC | -0.2 | 1e-06 |
mRNA | RP11-426L16.10 | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-09 |
mRNA | TCTA | GDSC1000 | pan-cancer | AAC | -0.2 | 3e-08 |
mRNA | ARF4 | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-09 |
mRNA | EAF2 | GDSC1000 | pan-cancer | AAC | -0.2 | 6e-05 |
mRNA | CD63 | CTRPv2 | pan-cancer | AAC | -0.2 | 7e-09 |
mRNA | RNF181 | CTRPv2 | pan-cancer | AAC | -0.2 | 4e-12 |
mRNA | DEPTOR | GDSC1000 | pan-cancer | AAC | -0.2 | 3e-08 |
mRNA | NRSN1 | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-06 |
mRNA | SLC2A8 | GDSC1000 | pan-cancer | AAC | -0.19 | 4e-07 |